BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Specialists Alarmed About Children Prescribed Opium-Derived Painkillers

  October 31, 2016

   · 

  1 min read
• Policy

  Does Johnson & Johnson’s Baby Powder Cause Cancer? Another Jury Says Yes

  October 31, 2016

   · 

  1 min read
• Biotech Beach

  Hundreds Of American Kids Are Suddenly Paralyzed, And Doctors Don’t Know Why

  October 31, 2016

   · 

  1 min read
• 

  Deals

  Merck KGaA Exploring Sale of Its Biosimilar Biz, Deal Could Fetch $1 Billion

  October 31, 2016

   · 

  2 min read
• BioCapital

  6 “Miracle” Drugs Big Pharma Now Regrets

  October 31, 2016

   · 

  1 min read
• Policy

  Arena Faces Shareholder Lawsuit for Failing to Tell the Whole Truth and Nothing But the Truth

  October 31, 2016

   · 

  1 min read
• 

  Policy

  OUCH! FDA Spurns Regeneron, Sanofi’s RA Drug Over Plant Deficiencies

  October 31, 2016

   · 

  2 min read
• 

  Pharm Country

  Ballsy Celgene Eyes $6 Billion in New Business

  October 31, 2016

   · 

  3 min read
• 

  Business

  Takeda, VCs and NYC Institutions Form Bridge Medicines to Grow Biotech in the Big Apple

  October 31, 2016

   · 

  3 min read
• 

  Business

  Bay Area CRO LakePharma Likely to Build in Worcester, Mass., Create 350 Jobs

  October 31, 2016

   · 

  2 min read